logo
Should You Throw Out Expired Vitamins? Why That Date Might Not Matter as Much as You Think

Should You Throw Out Expired Vitamins? Why That Date Might Not Matter as Much as You Think

CNETa day ago
Who hasn't been digging through a medicine cabinet only to find that their vitamins and other supplements have passed their expiration dates. It happens. Your gut reaction is to chuck them in the trash. After all, we do the same for food after we see that it's out of date, so why not supplements? The reality is that vitamins don't necessarily "go bad" the same way that food does. In fact, understanding what that date on the label actually means is a bit more complicated. In this guide we'll break down what happens to supplements over time and whether you should use them after the date on the bottle passes.
Do vitamins expire?
Your vitamin bottles most likely have a date on them, but that's not technically an expiration date. That's because your vitamins don't expire in the way that you may think. Because vitamins don't become unsafe when they "expire," the Food and Drug Administration doesn't even require a date to be put on the bottles. Most manufacturers still do, though, because there is a point when vitamins lose potency. This means that your vitamins and minerals may not be providing the full nutritional value you expect if they're past their shelf life.
Depending on your vitamins and supplements and what form they're in, they lose potency at different rates. Tablets and capsules tend to stay potent for longer than something like a chewable gummy vitamin.
The best way to store your vitamins is in a cool, dry place. Two of the worst places -- and two of the most common -- are in the bathroom and the kitchen. Both of these rooms run warm and damp, which can make your vitamins break down faster. Putting your vitamins in a closet or in a spot in your bedroom that's not getting direct sunlight can help prolong their potency.
How expired is 'too expired' for vitamins?
Ayrat Gabdrakhmanov/iStock/Getty Images
Though vitamins won't expire and become unsafe, they will lose potency, which means they're not doing you any good. Manufacturers put the dates on the bottle that signifies when the vitamins hit that point, so if you're past the "best by" date on a bottle, go ahead and toss them because, while they won't make you sick, they also won't help you.
Though it's not common, vitamins can become moldy or smelly, especially if they're not stored properly. If your vitamins are in this condition, throw them out immediately and get a new bottle. This is a situation where your vitamins can be unsafe to consume because of whatever contamination is happening with them.
There are currently no documented cases of "expired" vitamins becoming toxic or dangerous to people. Expired vitamins are really just a waste of time and not much else.
How long can you use vitamins after expiration date?
Although taking vitamins past their expiration date is OK, it will depend on how well you've stored them and if they have been opened. Other factors to consider are the type of vitamin and what it's made of. For example, vitamins in gummy form tend to degrade faster than those in tablet or capsule form because they are more prone to absorbing moisture. A good rule of thumb is that if mold is present, the smell is off or the consistency has changed, throw it out.
How to dispose of expired vitamins
After you've determined your vitamins are past the point of no return, it's important to get rid of them safely. Simply throwing them in the trash can be a risk, because children or even pets could end up getting a hold of them. And while you might be tempted to flush them down the toilet, that's not a good idea because old vitamins can still potentially contaminate the water.
The FDA recommends dumping the vitamins out of the bottle and into a plastic bag and mixing them with an "undesirable substance" like coffee grounds or cat litter. Seal the mixture in the bag and put that bag into your trash.
You can also take your vitamins to a drug take-back center in your community if you have one. While these are more commonly used for prescription drugs, you can also dispose of your vitamins so they can be handled safely.
The bottomWhile your vitamins won't technically expire, they will become useless after a period of time. Pay attention to the dates the manufacturers put on bottles so you know when your vitamins and supplements will stop working for you. As long as you're storing them properly, they will last as long as they're meant to -- and contribute to your overall health.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HRT ‘can raise breast cancer risk' in younger women
HRT ‘can raise breast cancer risk' in younger women

Yahoo

time16 minutes ago

  • Yahoo

HRT ‘can raise breast cancer risk' in younger women

Hormone replacement therapy can raise the risk of breast cancer in some younger women, a Lancet study suggests. An international team of researchers found the treatment was not linked to young onset breast cancer overall. But oestrogen plus progestin therapy appears to increase breast cancer risk by 10 per cent. Meanwhile, oestrogen hormone therapy use appeared to decrease breast cancer risk by 14 per cent. Hormone replacement therapy is a treatment used to help menopause symptoms. There are different types of HRT, which is used to treat menopause symptoms, available. They contain different hormones: some are oestrogen products; others contain progestogen and other types have both. These medicines can be taken or used in different ways and work by replacing the hormones oestrogen and progesterone, which can fall to lower levels as women approach the menopause. Most studies examining links between hormone therapy and breast cancer risk have been explored in older women. Previous work, which has focused on women who have already been through the menopause, suggest that oestrogen plus progestin hormone therapy is a risk factor for breast cancer. The researchers, led by academics from the National Institute of Environmental Health Sciences in the US, wanted to explore the risks among younger women on hormone therapy – who may take these drugs after gynaecological surgery or during perimenopause. The new meta-analysis published in the journal, Lancet Oncology, examined data drawn from previous studies of 459,476 women aged 16 to 54 years old. Some two per cent of this group (8,455) developed young-onset breast cancer, which means the disease was diagnosed before they were 55 years old. And 15 per cent of women involved in the study reported using hormone therapy, with oestrogen plus progestin hormone therapy and oestrogen being the most common types. 'Although the strength of these associations might vary by age at first use, duration of use, gynaecological surgery status, and other factors, unopposed oestrogen hormone therapy use appears to decrease breast cancer risk and oestrogen plus progestin therapy appears to increase breast cancer risk,' the authors wrote. 'The findings can be used to augment clinical recommendations for hormone therapy use in young women, for whom guidance was previously scarce.' Dr Kotryna Temcinaite, the head of research communications at Breast Cancer Now, said: 'These results are largely in line with what we already know about taking HRT for menopausal symptoms and its effects on breast cancer risk – for most people, the risk of developing breast cancer because of taking HRT is small and is outweighed by the benefits. 'Taking HRT is a very personal decision and, as such, it's vital that everyone has the information they need on the benefits and risks, discusses them with their GP or specialist team and is supported to make the choice that's right for them.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy
Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy

Yahoo

time17 minutes ago

  • Yahoo

Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy

Over the past year, many Elevance Health, Inc. (NYSE:ELV) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, if numerous insiders are selling, shareholders should investigate more. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In the last twelve months, the biggest single sale by an insider was when the Executive VP & President of Commercial Health Benefits, Charles Kendrick, sold US$3.2m worth of shares at a price of US$432 per share. That means that an insider was selling shares at around the current price of US$396. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern. Elevance Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below! View our latest analysis for Elevance Health If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar). Over the last three months, we've seen significant insider selling at Elevance Health. Specifically, Executive VP & CFO Mark Kaye ditched US$1.9m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain. For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Elevance Health insiders own 0.1% of the company, currently worth about US$103m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders. An insider hasn't bought Elevance Health stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Elevance Health. But note: Elevance Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment
Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment

Wall Street Journal

time20 minutes ago

  • Wall Street Journal

Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment

Regeneron Pharmaceuticals has won Food and Drug Administration accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma. Regeneron on Wednesday said the FDA green light covers Lynozyfic in adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent and an anti-CD38 monoclonal antibody.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store